What ’s new in the use of antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) DNA cross-linkers for cancer therapy?

.

Source: Expert Opinion on Biological Therapy - October 30, 2023 Category: Drugs & Pharmacology Authors: John A HartleyUCL Cancer Institute, London, UK Source Type: research